Skip to Content

CL 26 (Montelukast Sodium 10 mg (base))

Pill with imprint CL 26 is Beige, Four-sided and has been identified as Montelukast Sodium 10 mg (base). It is supplied by Macleods Pharmaceuticals Limited.

Montelukast is used in the treatment of allergic rhinitis; bronchospasm prophylaxis; asthma, maintenance; asthma; copd and belongs to the drug class leukotriene modifiers. There is no proven risk in humans during pregnancy. Montelukast 10 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for CL 26

Montelukast sodium 10 mg (base) CL 26

Montelukast Sodium

Imprint:
CL 26
Strength:
10 mg (base)
Color:
Beige
Shape:
Four-sided
Availability:
Prescription only
Drug Class:
Leukotriene modifiers
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Macleods Pharmaceuticals Limited
National Drug Code (NDC):
33342-0102

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide